Literature DB >> 17368441

VacA and HP-NAP, Ying and Yang of Helicobacter pylori-associated gastric inflammation.

Mario Milco D'Elios1, Cesare Montecucco, Marina de Bernard.   

Abstract

Helicobacter pylori is a Gram-negative bacterium which infects almost half of the population worldwide and represents the major cause of gastroduodenal pathologies, such as duodenal and gastric ulcer, gastric cancer, B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) and autoimmune gastritis. H. pylori colonization is followed by infiltration of the gastric mucosa by polymorphonuclear cells, macrophages and lymphocytes. Two of the major H. pylori virulence factors are the vacuolating cytotoxin (VacA) and the H. pylori neutrophil-activating protein (HP-NAP). VacA has been proposed as a modulator of immune cell function because of its capacity to interfere with antigen presentation and to inhibit T-cell activation. HP-NAP was designated as neutrophil-activating protein because it stimulates high production of oxygen radicals from neutrophils. We have recently demonstrated that HP-NAP is able to recruit leukocytes in vivo and to stimulate either neutrophils or monocytes to release IL-12, a key cytokine for the differentiation of naive Th cells into the Th1 phenotype. Altogether these evidences indicate that both VacA and HP-NAP play a major role in generating and maintaining the gastric inflammatory response associated with the H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17368441     DOI: 10.1016/j.cca.2007.02.026

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Endosome-mitochondria juxtaposition during apoptosis induced by H. pylori VacA.

Authors:  F Calore; C Genisset; A Casellato; M Rossato; G Codolo; M D Esposti; L Scorrano; M de Bernard
Journal:  Cell Death Differ       Date:  2010-04-30       Impact factor: 15.828

2.  Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.

Authors:  Ianko D Iankov; Iana H Haralambieva; Evanthia Galanis
Journal:  Vaccine       Date:  2010-12-21       Impact factor: 3.641

3.  Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein.

Authors:  Ianko D Iankov; Alan R Penheiter; Stephanie K Carlson; Evanthia Galanis
Journal:  J Immunol Methods       Date:  2012-06-28       Impact factor: 2.303

4.  Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway.

Authors:  Masaaki Nakayama; Junzo Hisatsune; Eiki Yamasaki; Hajime Isomoto; Hisao Kurazono; Masanori Hatakeyama; Takeshi Azuma; Yoshio Yamaoka; Kinnosuke Yahiro; Joel Moss; Toshiya Hirayama
Journal:  J Biol Chem       Date:  2008-11-07       Impact factor: 5.157

5.  Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer.

Authors:  Min Long; Jun Luo; Yan Li; Fang-Yin Zeng; Ming Li
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

Review 6.  Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications.

Authors:  Hua-Wen Fu
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

7.  Ulcerogenic Helicobacter pylori strains isolated from children: a contribution to get insight into the virulence of the bacteria.

Authors:  Inês Vitoriano; Kathy D Saraiva-Pava; Alexandra Rocha-Gonçalves; Andrea Santos; Ana I Lopes; Mónica Oleastro; Mónica Roxo-Rosa
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

8.  Lnc-SGK1 induced by Helicobacter pylori infection and highsalt diet promote Th2 and Th17 differentiation in human gastric cancer by SGK1/Jun B signaling.

Authors:  Yongliang Yao; Qingbo Jiang; Lixing Jiang; Jianhong Wu; Qinghui Zhang; Jianjun Wang; Huang Feng; Panpan Zang
Journal:  Oncotarget       Date:  2016-04-12

9.  Helicobacter pylori is associated with weakened pulmonary function and reduced incidence of allergic conditions in patients with chronic cough.

Authors:  Meng He; Yuanyuan Zheng; A'Huo Ma; Chunyi Zhang; Yuefang Yu; Hua Wang; Yefeng Chen; Min Xiang; Kelong Tao; Juxin Shen
Journal:  Exp Ther Med       Date:  2020-09-03       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.